Montserrat GarcClosas

发表

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

M. Beckmann, P. Fasching, K. Czene, 2017, Oncotarget.